This inventor holds 37 USPTO granted patents, primarily in Polynucleotide Separation. Top assignees: Transgenomic, Inc., Other. Active years: 1999-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gilroy, both of, CA (US) (2002)
- Palo Alto, CA (US) (1999 - 2005)
- Gilroy, CA (US) (2001 - 2010)
Company Filing History:
36 out of 69 
1 out of 834,570 Years Active: 1999-2010
Areas of Expertise:
Title: Innovations by Paul D. Taylor: Pioneering Nucleic Acid Variant Identification
Introduction: Paul D. Taylor, an accomplished inventor based in Gilroy, CA, has made significant contributions to the field of biotechnology. With a remarkable portfolio of 37 patents, Taylor has focused on innovative methods for identifying sequence variations in nucleic acid molecules, which can have profound implications for genetics and personalized medicine.
Latest Patents: Among his recent inventions, one notable patent pertains to a method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule. This invention utilizes a mismatch-specific endonuclease to cleave double-stranded nucleic acids containing mismatches, thereby preserving the integrity of the variant nucleotide. By ligating a double-stranded linker with a 3'-overhang to the variant nucleotide, Taylor's method facilitates efficient PCR and sequence-by-synthesis analyses. His innovative approach enhances the accuracy and efficiency of genetic sequencing, providing essential tools for researchers and clinicians.
Career Highlights: Throughout his career, Paul D. Taylor has worked with several prominent companies in the biotech industry, including Transgenomic, Inc. His experience at these organizations has shaped his inventive path and enabled him to contribute valuable methodologies to the scientific community.
Collaborations: Taylor's work has also been enriched by collaborations with renowned professionals in the field. Notable coworkers include Douglas T. Gjerde and Robert M. Haefele, with whom he has partnered to advance biotechnology innovations and explore new avenues for research.
Conclusion: Paul D. Taylor's dedication to innovation in nucleic acid technology exemplifies the impact that dedicated inventors can have on science and medicine. His 37 patents showcase a persistent commitment to enhancing our understanding of genetics, making significant strides towards more efficient and accurate nucleic acid analysis. As innovators like Taylor continue to develop groundbreaking methods, the future of biotechnology looks promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile